We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
251
Humana
HUM
$45.8B
$7.16M 0.09%
26,933
-5,162
-16% -$1.49M
PLD icon
252
Prologis
PLD
$137B
$7.14M 0.09%
99,239
+11,136
+13% +$760K
ES icon
253
Eversource Energy
ES
$28.1B
$7.11M 0.09%
88,216
+36,946
+72% +$2.54M
BCE icon
254
BCE
BCE
$19.8B
$6.96M 0.09%
156,634
+20,269
+15% +$874K
TAP icon
255
Molson Coors Class B
TAP
$7.71B
$6.95M 0.09%
116,488
-98,738
-46% -$6.1M
GWPH
256
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$6.95M 0.09%
41,200
– –
MPC icon
257
Marathon Petroleum
MPC
$91.2B
$6.94M 0.09%
115,930
+3,694
+3% +$232K
WBA
258
DELISTED
Walgreens Boots Alliance
WBA
$6.86M 0.09%
94,477
-830
-0.9% -$56.7K
EBAY icon
259
eBay
EBAY
$50.3B
$6.86M 0.09%
184,751
-95,167
-34% -$3.3M
PTLA
260
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$6.74M 0.09%
194,300
+30,000
+18% +$866K
ONCE
261
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$6.72M 0.09%
59,000
-100
-0.2% -$7.35K
ARQL
262
DELISTED
Arqule Inc
ARQL
$6.72M 0.09%
1,402,181
+237,453
+20% +$917K
VSM
263
DELISTED
Versum Materials, Inc.
VSM
$6.58M 0.08%
+130,840
New +$5.21M
FFIV icon
264
F5
FFIV
$23B
$6.58M 0.08%
41,908
-12,894
-24% -$2.07M
KURA icon
265
Kura Oncology
KURA
$901M
$6.57M 0.08%
396,000
+30,000
+8% +$462K
B
266
Barrick Mining
B
$62.6B
$6.56M 0.08%
478,100
+430,823
+911% +$5.57M
DRNA
267
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$6.56M 0.08%
447,500
– –
ROST icon
268
Ross Stores
ROST
$78.1B
$6.51M 0.08%
69,944
+44,065
+170% +$4.04M
RIGL icon
269
Rigel Pharmaceuticals
RIGL
$692M
$6.37M 0.08%
247,800
– –
TBPH icon
270
Theravance Biopharma
TBPH
$874M
$6.34M 0.08%
279,700
– –
CSX icon
271
CSX Corp
CSX
$96B
$6.34M 0.08%
254,091
+20,253
+9% +$469K
WBC
272
DELISTED
WABCO HOLDINGS INC.
WBC
$6.32M 0.08%
47,940
+41,212
+613% +$5.08M
ECL icon
273
Ecolab
ECL
$76.4B
$6.32M 0.08%
22,802
-756
-3% -$123K
NATI
274
DELISTED
National Instruments Corp
NATI
$6.25M 0.08%
140,776
+61,275
+77% +$2.78M
EWC icon
275
iShares MSCI Canada ETF
EWC
$6.13B
$6.21M 0.08%
224,749
-4,321
-2% -$116K
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.